Increased intestinal permeability in patients with inflammatory bowel disease

被引:1
|
作者
Welcker, K
Martin, A
Kölle, P
Siebeck, M
Gross, M
机构
[1] Internist Klin Dr Muller, D-81379 Munich, Germany
[2] Univ Klinikum Munchen, Chirurg Klin Innenstadt, Munich, Germany
[3] Krankenhaus Grosshansdorf, Grosshansdorf, Germany
关键词
inflammatory bowel disease; intestinal permeability; Crohn's disease; ulcerative colitis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Intestinal permeability can be measured by the sugar absorption test. This test is based on determining the ratio of the urinary excretion of a large and a small carbohydrate after oral administration. The aim of this study was to determine which combination of carbohydrates used in the test gives the highest correlation with disease activity in inflammatory bowel disease. 26 patients with Crohn's disease, 21 patients with ulcerative colitis and 27 healthy control subjects were included in the stud's The patients with inflammatory bowel disease had either minimal or highly active disease or were in remission. Two disaccharides (lactulose: L, and cellobiose: C) and two smaller carbohydrates (rhamnose:R, and mannitol:M) were given orally and the urinary excretion was measured by high pressure liquid chromatography followed by pulsed amperometric electrochemical detection on a gold electrode. The ratios C/R, L/R, C/M and L/M were used as indicators for intestinal permeability. There were no side effects of oral sugar administration. All patients tolerated the test well. Lactulose, rhamnose and cellobiose concentrations are easily be measured in the urine whereas mannitol measurement requires the use of an anion exchanger. This produced inconsistent results. Patients with Crohn's disease or with ulcerative colitis had increased permeability indices in comparison to healthy controls, even in remission. The L/R ratio gave a better differentiation between the healthy controls and patients with active disease than the other agents. Changes in disease activity are best reflected by use of cellobiose/rhamnose excretion quotient.
引用
收藏
页码:456 / 460
页数:5
相关论文
共 50 条
  • [1] Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease
    Teahon, K
    Somasundaram, S
    Smith, T
    Menzies, I
    Bjarnason, I
    GUT, 1996, 38 (06) : 864 - 869
  • [2] Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test
    Vanya A Gerova
    Simeon G Stoynov
    Dimitar S Katsarov
    Dobrin A Svinarov
    World Journal of Gastroenterology, 2011, 17 (17) : 2211 - 2215
  • [3] Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test
    Gerova, Vanya A.
    Stoynov, Simeon G.
    Katsarov, Dimitar S.
    Svinarov, Dobrin A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (17) : 2211 - 2215
  • [4] INTESTINAL PERMEABILITY COMPARED IN PEDIATRIC AND ADULT PATIENTS WITH INFLAMMATORY BOWEL-DISEASE
    ISSENMAN, RM
    JENKINS, RT
    RADOJA, C
    CLINICAL AND INVESTIGATIVE MEDICINE, 1993, 16 (03): : 187 - 196
  • [5] Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease
    Lacerda, Joana Franco
    Lagos, Ana Catarina
    Carolino, Elisabete
    Silva-Herdade, Ana Santos
    Silva, Manuel
    Sousa Guerreiro, Catarina
    NUTRIENTS, 2021, 13 (02) : 1 - 15
  • [6] A spotlight on intestinal permeability and inflammatory bowel diseases
    Rath, Timo
    Atreya, Raja
    Neurath, Markus F. F.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (09) : 893 - 902
  • [7] Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing
    Chang, Jeff
    Leong, Rupert W.
    Wasinger, Valerie C.
    Ip, Matthew
    Yang, Michael
    Tri Giang Phan
    GASTROENTEROLOGY, 2017, 153 (03) : 723 - +
  • [8] Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?
    Gandhi, Sumeet
    Narula, Neeraj
    Marshall, John K.
    Farkouh, Michael
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10) : 956 - 962
  • [9] Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission
    Dunleavy, Katie A.
    Rypstra, Chad R.
    Busciglio, Irene
    Eckert, Deborah
    Ryks, Michael
    Omerdic, Ellie
    Chedid, Victor G.
    Raffals, Laura E.
    Camilleri, Michael
    INFLAMMATORY BOWEL DISEASES, 2025,
  • [10] Serum Endocan Levels are Increased in Patients with Inflammatory Bowel Disease
    Voiosu, Theodor
    Balanescu, Paul
    Bengus, Andreea
    Voiosu, Andrei
    Baicus, Cristian Rasvan
    Barbu, Maria
    Ladaru, Anca
    Nitipir, Cornelia
    Mateescu, Bogdan
    Diculescu, Mircea
    Voiosu, Radu
    CLINICAL LABORATORY, 2014, 60 (03) : 505 - 510